Trial Profile
Effect of netupitant and palonosetron fixed dose combination on the pharmacokinetics of oral contraceptives in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Netupitant/palonosetron (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Chemotherapy-induced nausea and vomiting
- Focus Pharmacokinetics
- 17 Dec 2015 New trial record